120
Participants
Start Date
November 17, 2024
Primary Completion Date
July 1, 2026
Study Completion Date
September 1, 2026
MANP
MANP (modified atrial natriuretic peptide) is a peptide that is being developed for treatment of difficult to control/resistant hypertension.
Placebo Matched control
This is a placebo matched vehicle - Vehicle minus the active ingredient
ACTIVE_NOT_RECRUITING
Tristar Clinical Investigations, P.C., Philadelphia
RECRUITING
Superior Clinical Research, Smithfield
RECRUITING
Monroe Biomedical Research, Monroe
RECRUITING
Alta Pharmaceutical Research Center, Peachtree Corners
RECRUITING
Cowry Health, Acworth
RECRUITING
Arrow Clinical Trials, Daytona Beach
RECRUITING
Royal Research Corp, Hollywood
RECRUITING
Evolution Clinical Trials, Miami
RECRUITING
SM Research Center, Biscayne Park
RECRUITING
K&R Research LLC, Marion
RECRUITING
Revival Research Institute, LLC, Dearborn
RECRUITING
Aa Mrc Llc, Flint
RECRUITING
Cedar Crosse Research Center, Chicago
RECRUITING
Lynn Institute of the Ozarks, Little Rock
ACTIVE_NOT_RECRUITING
Prime Research, Coppell
RECRUITING
Clinical Investigations of Texas, Plano
RECRUITING
Revival Research, Sherman
RECRUITING
Dallas Renal Group, Dallas
RECRUITING
Prime Clinical Research, Mansfield
RECRUITING
East Texas Cardiology, Houston
RECRUITING
Pioneer Research Solutions, Houston
RECRUITING
Aavon Clinical Trials, Richmond
RECRUITING
Amicis Research Center - Beverly Hills, Beverly Hills
WITHDRAWN
Interventional Cardiology Medical Group, West Hills
RECRUITING
Amicis Research Center - Granada Hills, Granada Hills
RECRUITING
Amicis Research Site - Valencia, Valencia
RECRUITING
Office of Dr. Edward Portnoy MD, Westlake Village
RECRUITING
Orange County Research Center, Lake Forest
RECRUITING
Amicis Research Center - Palmdale, Palmdale
Lead Sponsor
Collaborators (2)
Mayo Clinic
OTHER
PPD Development, LP
INDUSTRY
E-Star BioTech, LLC
INDUSTRY